LivaNova (LIVN) Non Operating Income (2024 - 2026)
LivaNova (LIVN) reported Non Operating Income of -$5.7 million for Q1 2026, down 149.89% on a YoY basis from $11.4 million in Q1 2025, and down 33.84% sequentially from -$4.3 million in Q4 2025.
LivaNova (LIVN) Non Operating Income (2024 - 2026) Analysis & Trends
LivaNova (LIVN) has 3 years of Non Operating Income data on file, last reported at -$5.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 149.89% year-over-year to -$5.7 million; the trailing twelve-month figure through Mar 2026 stood at -$6.0 million (changed N/A YoY), and the FY2025 full-year result was -$2.7 million, down 105.61% from the prior year.
- Non Operating Income fell to -$5.7 million in Q1 2026, from -$4.3 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $35.2 million in Q4 2024 to a low of -$7.5 million in Q3 2025.
- A 3-year average of $9.0 million and a median of $3.6 million in 2025 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income tumbled 112.08% in 2025 and sank 149.89% in 2026, its largest moves.
- Tracing LIVN's Non Operating Income over 3 years: stood at $35.2 million in 2024, then plunged by 112.08% to -$4.3 million in 2025, then plunged by 33.84% to -$5.7 million in 2026.
- Business Quant data shows LIVN's Non Operating Income at -$5.7 million in Q1 2026, -$4.3 million in Q4 2025, and -$7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | -5.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.70 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -7.49 Mn |
| Mar 31, 2025 | 11.42 Mn |
| Dec 31, 2024 | 35.23 Mn |
| Sep 30, 2024 | 24.70 Mn |